Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Steven J. Barrett

dblp:29/5512 · DBLP profile ↗
← Back
2ranked-venue papers
0as first author
0since 2021 · last 2019
0000-0002-3570-3131ORCID · corroborated

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 2

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 2 heaviest of 3, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › network bioinformatics › biological network analysis › network analysis
causal network analysis
0.312017
CausalR: extracting mechanistic sense from genome scale data · Bioinform. 2017
Bioinformatics and computational biology › biological network › network biology
network inference
0.312017
CausalR: extracting mechanistic sense from genome scale data · Bioinform. 2017

Methods — techniques the papers use, named apart from their topics

sequential causal analysis of networks · 0.3
YearPublicationVenuePosition
2019 Benchmarking network propagation methods for disease gene identification
abstract
In-silico identification of potential target genes for disease is an essential aspect of drug target discovery. Recent studies suggest that successful targets can be found through by leveraging genetic, genomic and protein interaction information. Here, we systematically tested the ability of 12 varied algorithms, based on network propagation, to identify genes that have been targeted by any drug, on gene-disease data from 22 common non-cancerous diseases in OpenTargets. We considered two biological networks, six performance metrics and compared two types of input gene-disease association scores. The impact of the design factors in performance was quantified through additive explanatory models. Standard cross-validation led to over-optimistic performance estimates due to the presence of protein complexes. In order to obtain realistic estimates, we introduced two novel protein complex-aware cross-validation schemes. When seeding biological networks with known drug targets, machine learning and diffusion-based methods found around 2-4 true targets within the top 20 suggestions. Seeding the networks with genes associated to disease by genetics decreased performance below 1 true hit on average. The use of a larger network, although noisier, improved overall performance. We conclude that diffusion-based prioritisers and machine learning applied to diffusion-based features are suited for drug discovery in practice and improve over simpler neighbour-voting methods. We also demonstrate the large impact of choosing an adequate validation strategy and the definition of seed disease genes.
Sergio Picart-Armada, Steven J. Barrett, David R. Willé, Alexandre Perera-Lluna, Alex Gutteridge, Benoit H. Dessailly
PLoS Comput. Biol.2
2017 CausalR: extracting mechanistic sense from genome scale data
abstract
SUMMARY: Utilization of causal interaction data enables mechanistic rather than descriptive interpretation of genome-scale data. Here we present CausalR, the first open source causal network analysis platform. Implemented functions enable regulator prediction and network reconstruction, with network and annotation files created for visualization in Cytoscape. False positives are limited using the introduced Sequential Causal Analysis of Networks approach. AVAILABILITY AND IMPLEMENTATION: CausalR is implemented in R, parallelized, and is available from Bioconductor. CONTACT: [email protected]. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Glyn Bradley, Steven J. Barrett
Bioinform.2